Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

IRONMAN: International Registry for Men with Advanced Prostate Cancer

Clinical Trial Details

This clinical trial is for patients with Advanced Prostate Cancer. The purpose of this study is to learn more about prostate cancer and:

  • To describe the use of different therapies for advanced prostate cancer internationally; 
  • To describe specific treatment patterns and whether they are associated with differences in outcomes such as hospitalizations 
  • To identify associations between treatment sequences or combinations and overall survival; 
  • To define the patient experience of men with advanced prostate cancer and identify unmet needs in their treatment; 
  • To identify clinical and molecular disease subtypes that may predict for a reduction in cancer from individual treatments, combinations, or sequences. 

Outline of the study includes a baseline (demographic data, epidemiological data, treatment history, clinical and pathology, patient reported outcomes and physician questionnaire), and follow-up visit for a minimum of three years (follow-up bloods, patient reported outcomes, physician questionnaire, and clinical follow-up data) 

Key Eligibility: 

• Age 18 and older. 
• Histological or cytological confirmation of prostate adenocarcinoma 
• Detailed eligibility reviewed when you contact the study team. 

Study contact by location

Upper East Side - Manhattan


Amie Patel, RN

Angela Tan, RN

Primary Investigator(s)

Protocol ID(s)

Weill Cornell Medicine IRB #:




Open to Enrollment

Age Group